Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study

BACKGROUND & AIMS: Chronic liver disease (CLD) and cirrhosis are associated with immune dysregulation, leading to concerns that affected patients may be at risk of adverse outcomes following SARS-CoV-2 infection. We aimed to determine the impact of COVID-19 on patients with pre-existing liver di...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Hepatol
Main Authors: Marjot, Thomas, Moon, Andrew M., Cook, Jonathan A., Abd-Elsalam, Sherief, Aloman, Costica, Armstrong, Matthew J., Pose, Elisa, Brenner, Erica J., Cargill, Tamsin, Catana, Maria-Andreea, Dhanasekaran, Renumathy, Eshraghian, Ahad, García-Juárez, Ignacio, Gill, Upkar S., Jones, Patricia D., Kennedy, James, Marshall, Aileen, Matthews, Charmaine, Mells, George, Mercer, Carolyn, Perumalswami, Ponni V., Avitabile, Emma, Qi, Xialong, Su, Feng, Ufere, Nneka N., Wong, Yu Jun, Zheng, Ming-Hua, Barnes, Eleanor, Barritt, Alfred S., Webb, Gwilym J.
Format: Artigo
Jezik:Inglês
Izdano: European Association for the Study of the Liver. Published by Elsevier B.V. 2021
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7536538/
https://ncbi.nlm.nih.gov/pubmed/33035628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhep.2020.09.024
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki